sur MRM Health
MRM Health Secures €2.6M VLAIO Grant for Inflammatory Disease Research
MRM Health, a biopharmaceutical company located in Ghent, Belgium, has been awarded a €2.6 million research grant from Flanders Innovation and Entrepreneurship (VLAIO). This grant funds a three-year program focusing on developing new therapeutics for immune-mediated inflammatory diseases by exploring the microbiome's role. The program will leverage expertise from renowned Belgian academics to gain insights into bacterial patterns that contribute to these conditions.
The initiative aims to advance safe, oral Live Biotherapeutic Products (LBPs), opening avenues for innovative treatments without immunosuppressive effects. Collaboration with experts like Prof. Jeroen Raes and Prof. Dr. Bram Verstockt will utilize clinical samples to better understand microbe-driven inflammation, potentially revolutionizing treatment strategies for inflammatory diseases.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de MRM Health